These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 25740805)

  • 1. Re-appraisal of topical 1% voriconazole and 5% natamycin in the treatment of fungal keratitis in a randomised trial.
    Sharma S; Das S; Virdi A; Fernandes M; Sahu SK; Kumar Koday N; Ali MH; Garg P; Motukupally SR
    Br J Ophthalmol; 2015 Sep; 99(9):1190-5. PubMed ID: 25740805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Voriconazole versus natamycin as primary treatment in fungal corneal ulcers.
    Arora R; Gupta D; Goyal J; Kaur R
    Clin Exp Ophthalmol; 2011 Jul; 39(5):434-40. PubMed ID: 21105974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjunctive Oral Voriconazole Treatment of Fusarium Keratitis: A Secondary Analysis From the Mycotic Ulcer Treatment Trial II.
    Prajna NV; Krishnan T; Rajaraman R; Patel S; Shah R; Srinivasan M; Devi L; Das M; Ray KJ; O'Brien KS; Oldenburg CE; McLeod SD; Zegans ME; Acharya NR; Lietman TM; Rose-Nussbaumer J;
    JAMA Ophthalmol; 2017 Jun; 135(6):520-525. PubMed ID: 28426856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mycotic ulcer treatment trial: a randomized trial comparing natamycin vs voriconazole.
    Prajna NV; Krishnan T; Mascarenhas J; Rajaraman R; Prajna L; Srinivasan M; Raghavan A; Oldenburg CE; Ray KJ; Zegans ME; McLeod SD; Porco TC; Acharya NR; Lietman TM;
    JAMA Ophthalmol; 2013 Apr; 131(4):422-9. PubMed ID: 23710492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative evaluation of topical versus intrastromal voriconazole as an adjunct to natamycin in recalcitrant fungal keratitis.
    Sharma N; Chacko J; Velpandian T; Titiyal JS; Sinha R; Satpathy G; Tandon R; Vajpayee RB
    Ophthalmology; 2013 Apr; 120(4):677-81. PubMed ID: 23246119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for low vision related functioning in the Mycotic Ulcer Treatment Trial: a randomised trial comparing natamycin with voriconazole.
    Rose-Nussbaumer J; Prajna NV; Krishnan T; Mascarenhas J; Rajaraman R; Srinivasan M; Raghavan A; Oldenburg CE; O'Brien KS; Ray KJ; Porco TC; McLeod SD; Acharya NR; Keenan JD; Lietman TM;
    Br J Ophthalmol; 2016 Jul; 100(7):929-932. PubMed ID: 26531051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Oral Voriconazole Versus Oral Ketoconazole as an Adjunct to Topical Natamycin in Severe Fungal Keratitis: A Randomized Controlled Trial.
    Sharma N; Singhal D; Maharana PK; Sinha R; Agarwal T; Upadhyay AD; Velpandian T; Satpathy G; Titiyal JS
    Cornea; 2017 Dec; 36(12):1521-1527. PubMed ID: 28902012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of natamycin and voriconazole for the treatment of fungal keratitis.
    Prajna NV; Mascarenhas J; Krishnan T; Reddy PR; Prajna L; Srinivasan M; Vaitilingam CM; Hong KC; Lee SM; McLeod SD; Zegans ME; Porco TC; Lietman TM; Acharya NR
    Arch Ophthalmol; 2010 Jun; 128(6):672-8. PubMed ID: 20547942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Oral Voriconazole on Fungal Keratitis in the Mycotic Ulcer Treatment Trial II (MUTT II): A Randomized Clinical Trial.
    Prajna NV; Krishnan T; Rajaraman R; Patel S; Srinivasan M; Das M; Ray KJ; O'Brien KS; Oldenburg CE; McLeod SD; Zegans ME; Porco TC; Acharya NR; Lietman TM; Rose-Nussbaumer J;
    JAMA Ophthalmol; 2016 Dec; 134(12):1365-1372. PubMed ID: 27787540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vision-Related Quality-of-Life Outcomes in the Mycotic Ulcer Treatment Trial I: A Randomized Clinical Trial.
    Rose-Nussbaumer J; Prajna NV; Krishnan KT; Mascarenhas J; Rajaraman R; Srinivasan M; Raghavan A; Oldenburg CE; O'Brien KS; Ray KJ; McLeod SD; Porco TC; Lietman TM; Acharya NR; Keenan JD;
    JAMA Ophthalmol; 2015 Jun; 133(6):642-6. PubMed ID: 25764482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between in vitro susceptibility to natamycin and voriconazole and clinical outcomes in fungal keratitis.
    Sun CQ; Lalitha P; Prajna NV; Karpagam R; Geetha M; O'Brien KS; Oldenburg CE; Ray KJ; McLeod SD; Acharya NR; Lietman TM;
    Ophthalmology; 2014 Aug; 121(8):1495-500.e1. PubMed ID: 24746358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic response time of topical voriconazole 1% and intrastromal voriconazole 0.05% versus topical natamycin 5% monotherapy in Fusarium keratitis in rabbit.
    Edwar L; Janna YM; Rozaliyani A; Louisa M
    Mycoses; 2020 Oct; 63(10):1128-1132. PubMed ID: 32780874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical interventions for fungal keratitis.
    FlorCruz NV; Evans JR
    Cochrane Database Syst Rev; 2015 Apr; 2015(4):CD004241. PubMed ID: 25855311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regression Discontinuity and Randomized Controlled Trial Estimates: An Application to The Mycotic Ulcer Treatment Trials.
    Oldenburg CE; Venkatesh Prajna N; Krishnan T; Rajaraman R; Srinivasan M; Ray KJ; O'Brien KS; Glymour MM; Porco TC; Acharya NR; Rose-Nussbaumer J; Lietman TM
    Ophthalmic Epidemiol; 2018 Aug; 25(4):315-322. PubMed ID: 29718751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful salvage treatment of Scedosporium apiospermum keratitis with topical voriconazole after failure of natamycin.
    Al-Badriyeh D; Leung L; Davies GE; Stewart K; Kong D
    Ann Pharmacother; 2009 Jun; 43(6):1139-42. PubMed ID: 19435962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management Algorithm for Fungal Keratitis: The TST (Topical, Systemic, and Targeted Therapy) Protocol.
    Sharma N; Sahay P; Maharana PK; Singhal D; Saluja G; Bandivadekar P; Chako J; Agarwal T; Sinha R; Titiyal JS; Satpathy G; Velpandian T
    Cornea; 2019 Feb; 38(2):141-145. PubMed ID: 30334872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of intrastromal voriconazole injection and topical voriconazole in the treatment of recalcitrant Fusarium keratitis.
    Siatiri H; Daneshgar F; Siatiri N; Khodabande A
    Cornea; 2011 Aug; 30(8):872-5. PubMed ID: 21448063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical Chlorhexidine 0.2% versus Topical Natamycin 5% for the Treatment of Fungal Keratitis in Nepal: A Randomized Controlled Noninferiority Trial.
    Hoffman JJ; Yadav R; Sanyam SD; Chaudhary P; Roshan A; Singh SK; Singh SK; Mishra SK; Arunga S; Hu VH; Macleod D; Leck A; Burton MJ
    Ophthalmology; 2022 May; 129(5):530-541. PubMed ID: 34896126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of pretreatment with antifungal agents on clinical outcomes in fungal keratitis.
    Sun CQ; Prajna NV; Krishnan T; Rajaraman R; Srinivasan M; Raghavan A; O'Brien KS; McLeod SD; Acharya NR; Rose-Nussbaumer J;
    Clin Exp Ophthalmol; 2016 Dec; 44(9):763-767. PubMed ID: 27329780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycotic Antimicrobial Localized Injection: A Randomized Clinical Trial Evaluating Intrastromal Injection of Voriconazole.
    Narayana S; Krishnan T; Ramakrishnan S; Samantaray PP; Austin A; Pickel J; Porco T; Lietman T; Rose-Nussbaumer J
    Ophthalmology; 2019 Aug; 126(8):1084-1089. PubMed ID: 30904540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.